Matthew Wallis
MB ChB FRCR
Matthew moved to Cambridge in 2007 after 19 years as Director of the Warwickshire Solihull and Coventry Breast Screening Service.
President EUSOBI 2008-2010.
His major research interest is optimisation of all stages of the breast cancer pathway from mammographic image production and display to trials to investigate limiting the side effects of current treatment of lower risk disease. His 149 peer reviewed publications has informed standard setting in image quality, radiology and surgery across the world. He has a long-standing interest in DCIS and is the Chief Investigator of Low RIsk DCIS trial.
Title: DCIS and Atypia - Sloane
Atypia: I will mainly discuss the recent Sloane papers Freeman K, Breast screening atypia and subsequent development of cancer: an observational analysis of the Sloane atypia prospective cohort in England BMJ 2024 e077039 doi:10.1136/bmj-2023-077039 and Freeman K,, Evidence-informed recommendations on managing breast screening atypia: perspectives from an expert panel consensus meeting reviewing results from the Sloane atypia project BJR 2004: 97;324–330, https://doi.org/10.1093/bjr/tqad053 together with any recent guidelines.
DCIS: I will summarise the most recent papers on biology and prediction of upgrade, review the most recent Sloane publications and update you on the current position of the Low Risk DCIS trials. Potentially COMET may have published by the time of the meeting